These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4108884)
1. Chemoresistance to Isoxyl. Its determination and its evaluation. Muzikravić T Antibiot Chemother; 1970; 16():177-81. PubMed ID: 4108884 [No Abstract] [Full Text] [Related]
2. Comparison of the sensitivity to ethionamide, thiacetazone and isoxyl of tubercle bacilli from previously untreated patients in Tokyo. Fukuhara Y; Kobayashi H; Hokama S Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):57-61. PubMed ID: 4097677 [No Abstract] [Full Text] [Related]
3. [Frequency of Conteben resistance and its significance in the occurrence of isoxyl (4,4'-diisoamyloxythiocarbanilide) resistance in tubercle bacilli]. Meissner G Prax Pneumol; 1965 Jul; 19(7):387-95. PubMed ID: 4953606 [No Abstract] [Full Text] [Related]
4. [The resistance of Mycobacterium tuberculosis to ethionamide, thiosemicarbazone and isoxyl and their relations to each other]. Eule H; Werner E Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):247-58. PubMed ID: 4968300 [No Abstract] [Full Text] [Related]
5. Experiences with Isoxyl in the treatment of kidney tuberculosis. Strauss I Antibiot Chemother; 1970; 16():182-6. PubMed ID: 4108886 [No Abstract] [Full Text] [Related]
6. [Antitubercular properties of isoxyl (4,4-di-isoamyl-oxycarbanilid)]. Janowiec M Gruzlica; 1969 May; 37(5):417-23. PubMed ID: 4979708 [No Abstract] [Full Text] [Related]
7. [Studies on the antituberculous activity of 4, 4'-diisoamyloxythiocarvanilide in vitro]. Maekawa N; Tsukuma S; Kamada M; Iawi K; Saiga S Bull Chest Dis Res Inst Kyoto Univ; 1968 Sep; 2(1):147-54 passim. PubMed ID: 4979433 [No Abstract] [Full Text] [Related]
8. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis. Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218 [TBL] [Abstract][Full Text] [Related]
9. On the clinical effectiveness of Isoxyl. Tousek J Antibiot Chemother; 1970; 16():149-55. PubMed ID: 4943580 [No Abstract] [Full Text] [Related]
10. [Treatment with new antitubercular agents]. Gartmann J Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079 [No Abstract] [Full Text] [Related]
16. [Comparative study of thiocarbonylides (isoxyl and ethoxide) under experimental and clinical conditions]. Shmelev NA; Kozulitsyna TI; Utkin VV; Poleshchuk AK; Stepanian ES Probl Tuberk; 1966; 44(6):13-23. PubMed ID: 4968672 [No Abstract] [Full Text] [Related]
17. [Sensitivity testing of tubercle bacteria for diisoamyloxythiocarbanilide]. Gubler HU; Friedrich T Schweiz Med Wochenschr; 1965 Dec; 95(49):1691-3. PubMed ID: 4959232 [No Abstract] [Full Text] [Related]
18. Observations on resistance, regional distribution and inter-laboratory differences in resistance to thioacetazone in Turkey. Gürsel A; Ulgenalp I; Gürdag G Bull Int Union Tuberc; 1971 Dec; 46():29-32. PubMed ID: 4118742 [No Abstract] [Full Text] [Related]
19. The ethionamide sensitivity of East African strains of Mycobacterium tuberculosis resistant to thiacetazone. Lefford MJ Tubercle; 1969 Mar; 50(1):7-13. PubMed ID: 4181091 [No Abstract] [Full Text] [Related]
20. [Comparative data from an experimental-clinical study of new antituberculosis drugs]. Utkin VV Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726 [No Abstract] [Full Text] [Related] [Next] [New Search]